Modavar Pharmaceuticals Opens 22,000 Square Foot Manufacturing Facility, Bolstering Frederick, Maryland Biotech Hub – BioBuzz

Modavar Pharmaceuticals Opens 22,000 Square Foot Manufacturing Facility, Bolstering Frederick, Maryland Biotech Hub
Modavar Pharmaceuticals (Modavar), a wholly-owned subsidiary of Indian pharma giant Cadila Pharmaceuticals, recently opened a brand new, state-of-the-art, 22,000 square foot manufacturing facility in Frederick, Maryland, adding a prestigious new life science company to the
Modavar develops and manufactures its own generic drug formulations and co-develops products with organizations via its
Contract Manufacturingarm. The company currently has six approved Abbreviated New Drug Applications (ANDA) and 14 ANDAs filed with the U.S. Food and Drug Administration (FDA). The company has deep expertise in cGMP manufacturing, high volume production, and quality assurance, all backed by the capabilities of Cadila, a large, global pharmaceutical company with a history dating back to the 1960s. The company has a particular focus on developing products to better serve the unique dosage needs of pediatric and geriatric patients.

Related Keywords

Maryland ,United States ,Washington ,Frederick County ,American ,Emad Hassan ,Modavar Frederick ,Modavar Pharmaceuticals ,Drug Administration ,Cadila Pharmaceuticals ,Modavar Pharmaceuticals Opens ,Foot Manufacturing Facility ,Bolstering Frederick ,Maryland Biotech ,Abbreviated New Drug Application ,Chief Science ,Mega Beads ,Biohealth Capital Region ,மேரிலாந்து ,ஒன்றுபட்டது மாநிலங்களில் ,வாஷிங்டன் ,ஃப்ரெடரிக் கவுண்டி ,அமெரிக்கன் ,காடிலா மருந்துகள் ,கால் உற்பத்தி வசதி ,மேரிலாந்து பயோடெக் ,தலைமை அறிவியல் ,மெகா மணிகள் ,